Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

- Nederlands
- Deutsch

Navigating sensitive situations: exclusive insights from DSMB experts

Fiercebiotech.com

Click here to subscribe to Fiercebiotech.com

Loading...

8 months ago

Html
Text

Bookmark This Webinar

This week's Fierce Biotech is brought to you by Advarra.
Trouble viewing? Click here.

DSMB Best Practices and Behind the Scenes Insights

What is your plan for sensitive situations? How are you ensuring member expertise?

Learn about how DSMBs address these concerns in our latest on-demand webinar, DSMB Best Practices and Behind the Scenes Insights.

Dr. Barbara Schneider and James Riddle share insights from 20+ years in the field, including bias elimination strategies and what FDA's February 2024 draft guidance means for sponsors.

Can't watch the webinar right now? Register anyway, and we'll send you the recording to watch at your convenience.

Bookmark This Webinar

Advarra.com
6100 Merriweather Dr., Suite 600, Columbia, MD 21044 Copyright © 2024 Advarra. All Rights Reserved.

If you no longer wish to receive communications from Advarra, please opt out here.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017

Share on

Loading...

Other newsletters from Fiercebiotech.com

| 11.23.24 | House passes sweeping nonprofits bill; Trump taps Dr. Oz to run CMS Fiercebiotech.com
Yesterday at 13:32
| 11.22.24 | Halozyme ends $2B pursuit of 'unwilling' Evotec; Lexicon cuts 60% of workforce Fiercebiotech.com
Yesterday at 20:32
| 11.22.24 | Rett patient dies in Neurogene trial; AZ scraps opioid disorder drug over antifungal interaction Fiercebiotech.com
Yesterday at 17:35

More newsletters from Fiercebiotech.com

Loading...

Related newsletters

© 2024

Information
Terms and Conditions
Privacy

Home
Publishers
Categories
Trending
Inbox

Create Account
Sign in

© 2024

Information
Terms and Conditions
Privacy

- Nederlands
- Deutsch